Human T-lymphotropic virus 1
"Human T-lymphotropic virus 1" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A strain of PRIMATE T-LYMPHOTROPIC VIRUS 1 isolated from mature T4 cells in patients with T-lymphoproliferation malignancies. It causes adult T-cell leukemia (LEUKEMIA-LYMPHOMA, T-CELL, ACUTE, HTLV-I-ASSOCIATED), T-cell lymphoma (LYMPHOMA, T-CELL), and is involved in mycosis fungoides, SEZARY SYNDROME and tropical spastic paraparesis (PARAPARESIS, TROPICAL SPASTIC).
Descriptor ID |
D015368
|
MeSH Number(s) |
B04.613.807.200.725.400 B04.820.650.200.725.400
|
Concept/Terms |
Human T-lymphotropic virus 1- Human T-lymphotropic virus 1
- Human T lymphotropic virus 1
- Leukemia Lymphoma Virus I, Adult T Cell
- Adult T-Cell Leukemia-Lymphoma Virus I
- ATLV
- HTLV-I
- Human T Cell Leukemia Virus I
- HTLV-1
- T Cell Leukemia Virus I, Human
- Human T-Cell Leukemia Virus I
- Leukemia Virus I, Human T-Cell
- T-Cell Leukemia Virus I, Human
- Adult T Cell Leukemia Lymphoma Virus I
- Leukemia Virus I, Human T Cell
|
Below are MeSH descriptors whose meaning is more general than "Human T-lymphotropic virus 1".
Below are MeSH descriptors whose meaning is more specific than "Human T-lymphotropic virus 1".
This graph shows the total number of publications written about "Human T-lymphotropic virus 1" by people in this website by year, and whether "Human T-lymphotropic virus 1" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 2 | 0 | 2 |
1997 | 1 | 0 | 1 |
2000 | 0 | 1 | 1 |
2007 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Human T-lymphotropic virus 1" by people in Profiles.
-
Human T-cell leukemia virus type 1 (HTLV-1) p12I down-modulates ICAM-1 and -2 and reduces adherence of natural killer cells, thereby protecting HTLV-1-infected primary CD4+ T cells from autologous natural killer cell-mediated cytotoxicity despite the reduction of major histocompatibility complex class I molecules on infected cells. J Virol. 2007 Sep; 81(18):9707-17.
-
HTLV type 1 Tax transduction in microglial cells and astrocytes by lentiviral vectors. AIDS Res Hum Retroviruses. 2000 Nov 01; 16(16):1771-6.
-
Transfer of host T-cell membrane HLA-DR and CD25 to target cells by human retroviruses. J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Mar 01; 17(3):196-202.
-
Differential expression of alternatively spliced pX mRNAs in HTLV-I-infected cell lines. Leukemia. 1997 Jun; 11(6):866-70.
-
Host cell-derived complement control proteins CD55 and CD59 are incorporated into the virions of two unrelated enveloped viruses. Human T cell leukemia/lymphoma virus type I (HTLV-I) and human cytomegalovirus (HCMV). J Immunol. 1995 Nov 01; 155(9):4376-81.
-
HTLV-I activates complement leading to increased binding to complement receptor-positive cells. AIDS Res Hum Retroviruses. 1995 Sep; 11(9):1115-22.
-
Phylogenetic associations of human and simian T-cell leukemia/lymphotropic virus type I strains: evidence for interspecies transmission. J Virol. 1994 Apr; 68(4):2693-707.
-
Phylogenetic study of ten new HTLV-I strains from the Americas. AIDS Res Hum Retroviruses. 1994 Jan; 10(1):103-6.
-
The human T-cell leukemia/lymphotropic virus type I p12I protein cooperates with the E5 oncoprotein of bovine papillomavirus in cell transformation and binds the 16-kilodalton subunit of the vacuolar H+ ATPase. J Virol. 1993 Dec; 67(12):7701-4.
-
The p12I, p13II, and p30II proteins encoded by human T-cell leukemia/lymphotropic virus type I open reading frames I and II are localized in three different cellular compartments. J Virol. 1993 Apr; 67(4):2360-6.